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        Gel dosage forms are successfully used as drug delivery 
systems to control drug release and protect the medicaments 
from a hostile environment. The main objective of the present 
investigation is to formulate and evaluate in situ gels of moxiflo-
xacin for the treatment of periodontitis using gellan gum and 
sodium alginate based on the concept of ion activated systems. 
The system utilizes polymers that exhibit sol-to-gel phase 
transition due to change in specific physico-chemical parameters. 
Sol-to-gel transformation occurred in the presence of monovalent 
/divalent cations. It was found that increase in the concentration 
of calcium ions produced stronger gels. Formulations were 
evaluated for gelling capacity, drug content, clarity, viscosity, gel 
strength, spread ability, microbiological studies and in vitro 
release. The results shown by the above characterization studies 
were found to be satisfactory. Experimental part showed that 
viscosity of sols and gel strength was increased with increase in 
the concentration of polymers and the sustained release of drug 
was observed. The formulations were therapeutically efficacious, 
sterile and provided sustained release of the drug over a period 
of time. These results demonstrated that the developed system 
is an alternative to conventional drug delivery systems, provides 
patient compliance and economical. 
 




Dental diseases are recognized as the 
major public problem throughout the world 
and these are amongst the most widespread 
chronic disorders affecting the mankind (Swati 
et al., 2010). Periodontal disease refers to the 
inflammatory processes that occur in the tissues 
surrounding the teeth in response to bacterial 
accumulations or dental plaque on the teeth 
(Jemin and Salomon 2006). It is characterized 
by loss of bone, collagen support of affected 
teeth. The progression of the disease is related 
to the colonization of microorganisms, 
including Porphyromonas gingivalis, Prevotella 
intermedia, Actinobacillus actinomycetemcomitans, 
Tannerella forsythia and Treponema denticola 
(Mohammed et al., 2008, 2009). 
To eliminate bacterial infections, 
antibiotics are administered systemically but the 
repeated and long term use of systemic 
antibiotics is associated with toxic adverse 
effects. These consequences can be solved by 
delivering the drug at the desired target site (i.e. 
periodontal pocket) to show local therapeutic 
action. The main advantage of the local route 
of the drug delivery is the reduction of drug 
dose and possibility to increase the 
concentration of the drug in the periodontal 
pockets, at the same time keeping compara-
tively low systemic drug concentrations 
(Mohammed et al., 2008; Pragati et al.,  2009). 
At present various local drug delivery 
systems available for treating periodontitis like 
fibers, films, strips and gels etc,. Among this gel 
formulations have some advantages over 
conventional dosage forms as sustained and 
prolonged release of the drug, good stability 
and biocompatibility characteristics make the  
in situ gel dosage forms very reliable. Use        
of biodegradable and water soluble polymers 
for the in situ gel formulations can make          
them more acceptable and excellent drug 
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delivery systems (Nirmal et al., 2010; Vyas et al., 
2011). 
Moxifloxacin is a fourth generation 
fluoroquinolone with a broad antibacterial 
activity against Gram-positive and Gram-
negative bacteria. Moxifloxacin shows 
bactericidal, concentration dependent, anti-
infective. It interferes with bacterial survival by 
binding to DNA gyrase (topoisomerase II) and 
topoisomerase IV, essential bacterial enzymes 
involved in the replication, translation, repair 
and recombination of deoxyribonucleic acid 
(Ingo et al., 2002; Harish et al., 2009). 
Hence, the aim of present work is to 
develop and evaluate the in situ gel containing 
moxifloxacin as a local drug delivery within the 




Materials and reagents  
Moxifloxacin was kindly obtained from 
Aurabindo pharmaceuticals, Hydrabad. Gellan 
gum was provided by Hi Media laboratories 
Ltd, Mumbai and sodium alginate was obtained 
from S.D. Fine-Chem limited, Mumbai. All the 
other materials used were of analytical grade. 
 
Preparation of in situ gelling system 
Gellan gum and sodium alginate 
solutions of various concentrations were 
prepared by adding the gum to deionised water 
containing 0.17% w/v sodium citrate and 
heated to 90°C while stirring. After cooling to 
below 40°C, moxifloxacin was dissolved in 
ethanol water and was added to the solution. 
The mixture was stirred by using a magnetic 
stirrer to ensure thorough mixing (Shastri et al., 
2010) (Table I).  
 
Evaluation of gels 
 Compatibility studies carried out by 
FTIR showed, both drugs and polymers             
were compatible. The clarity of formulations 
determined by visual inspection under black 
and white background (Nirmal et al., 2010) and 
the pH of the in situ sols was determined using 
a calibrated pH meter.  
 
In vitro gelling capacity 
The gelling capacity of the formed gel 
was determined by visual inspection and grades 
were allotted as per the gel integrity, weight and 
rate of formation of gel with respect to time 
and CaCl2 required for each formulation for the 
sol-gel transition was noted (Shastri et al., 2010).  
 
Spreadability (Harish et al., 2009) 
For the determination of spreadability, 
excess of sample was applied between the two 
glass slides and was compressed to uniform 
thickness by placing 1000 g weight for 5 min. 
Weight (50 g) was added to the pan and the 
time required for separating the two slides, i.e. 
the time in which the upper glass slide moves 
over the lower plate was taken as measure of 
spreadability (S).  
 
Spreadability (g.cm/s) (S)=M×L/T 
Where M = weight tide to upper slide 
L = length moved on the glass slide 
T = time taken 
 
In situ release studies 
Drug release studies from the in situ gel 
were carried out by using a cellophane 
membrane. Apparatus was designed as it is a 
glass tube had a length of 10.5 cm and a 
diameter of 2.1 cm. The lower base was tied 
with cellophane membrane containing in situ  
gel and this was placed in a beaker containing 
100 mL of phosphate buffer pH 6.8 (simulated 
salivary pH) as diffusion medium which is 
maintained at 37°C with 50 RPM. Samples            
(5 mL) were withdrawn at different time 
intervals from the reservoir till the gel was 
completely eroded (3 hours). The cumulative 
percent drug release was determined by 
measuring the absorbance at 289 nm 
(Himanshu et al., 2009). 
 
Measurement of viscosity of sols 
Viscosity determinations for the prepa-
red formulations were carried out on a Brook-
field digital viscometer using spindle No 4. 
Viscosity of in situ gelling solutions was measu-
red at different angular velocities at a tempera-
ture of 37°C. A typical run comprised changing 
of the angular velocity from 0.0 to 100 rpm. 
The averages of two readings were used to 
calculate the viscosity (Shastri et al., 2010). 
 
Determination of gel strength 
The method by which the properties               
of polymeric system may be convenien-                      
tly   determined   is   texture    profile   analysis.  
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A TA-XT2 Texture analyzer is used. The 
experiment was done by placing the gels in 
standard Beaker below the probe. In this an 
analytical probe is then immersed into the 
sample. The Texture Analyzer was set to the 
‘gelling strength test’ mode or compression 
mode with a test-speed of 1.0 mm/s. An 
acquisition rate of 50 points per seconds and a 
trigger force of 5 g were selected. An aluminum 
probe of 7.6 cm diameter was used for all the 
samples. The study was carried out at room 
temperature. The force required to penetrate 
the gel was measured as gel strength in terms of 




The microbiological studies were carried 
out on the plain drug solution and optimized 
formulation G3 of different concentrations             
as 100, 200, 300 and 400 μg/mL against 
different microorganisms. E.coli, Salmonella, 
klebsiella and Pseudomonas were used as the test 
microorganisms. A layer of nutrient agar                      
(20 mL) seeded with the test microorganism 
(0.2 mL) was allowed to solidify in the 
petriplate. Cups were made on the          
solidified agar layer with the help of sterile  
borer at 6 mm diameter. Appropriate amount  
of   drug  solution  was poured   into   the  cups.  
Table I. Formulation of in situ gel of Moxifloxacin with various polymers at different 
concentrations 
 
Formulation code G1 G2 G3 S1 S2 S3 
Gellan gum (% w/v) 0.4 0.5 0.6 - - - 
Sodium alginate (% w/v) - - - 1.5 2 2.5 
Sodium citrate (% w/v) 0.17 0.17 0.17 0.17 0.17 0.17 
Moxifloxacin (µg) 50 50 50 50 50 50 
 
 

















G1 7.1 39.70 95.03 12.65 + 4.1 
G2 6.9 29.34 95.10 15.00 +++ 6.5 
G3 7.2 23.27 97.16 16.50 +++ 7.1 
S1 7.2 45.00 95.31 12.02 + 4.0 
S2 7.1 35.52 97.23 15.54 ++ 6.0 
S3 7.0 25.96 96.17 16.20 +++ 6.5 
+ - Average;  ++ - Good; +++ - Excellent 
 
 





Zero order First order Higuchi Korsmeyer et al. 
R2 R2 R2 n R2 
G1 0.969 0.951 0.719 0.359 0.956 
G2 0.989 0.983 0.802 0.290 0.981 
G3 0.912 0.910 0.915 1.155 0.906 
S1 0.937 0.917 0.708 0.364 0.938 
S2 0.969 0.963 0.778 0.472 0.974 
S3 0.979 0.970 0.792 0.472 0.946 
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After keeping petriplates at room temperature 
for 4 hours, the plates were incubated at 37°C 
for 24 hours. The zone of inhibition was 
obtained. The diameter of zone of inhibition 
was measured by an antibiotic zone finder 
(Himanshu and Aarti, 2009). 
 
RESULTS AND DISCUSSION 
In the present investigation, an attempt 
was made to develop and evaluate in situ gel 
formulation of moxifloxacin having controlled 
release characteristics for direct placement into 
the periodontal pocket. The two main 
prerequisites of an in situ gelling system are 
viscosity and gelling capacity. To instill easily at 
the affected site the formulation must possess 
optimum viscosity, which then undergoes a 
rapid sol-gel transition due to ionic interaction. 
Sol to gel transformation of in situ gels occurs 
in the presence of either monovalent or 
divalent cations at the site of administration. In 
these formulations the calcium chloride was a 
source of divalent cation for internal ionotropic 
gelation for polymers.  
Experimental part (Table II) have 
showed that the formulation G3 (gellan gum 
0.6 % w/v) and formulation S3 (sodium 
alginate 2.5 % w/v) were satisfactory to cause 
gelation. Drug content of all formulations was 
found between 95.1 to 97.23 % w/w. Clarity 
test for the prepared formulations has done by 
visual inspection under black and white 
background, there was no evidence of 
contamination, the entire formulations passes 
clarity test. Aqueous gellan gum and sodium 
alginate sols exhibited pH values in the range of 
6.9 to 7.2 at 25°C. Spreadability was decreasing 
by increasing the concentration of polymer. 
Formulation G3 shows least Spreadability 
(23.27 g cm/s) and formulation S1 shows more 
Spreadability (45 g cm/s).     
The viscosity of in situ sols was 
determined by Brookfield viscometer (Table 
II). Among the all formulations, S1 (Sodium 
alginate 1.5%) shows least viscosity (12.02 Pa.s) 
and G3 was more (16.5 Pa.s). The formulations 
S2 and G2 were nearly same (15.54 and 15.0 
Pa.s respectively). This says increase in polymer 
concentration causes increase in viscosity of the 
sols. The gel strength of in situ gels was 
determined by A TA-XT2 Texture analyzer. 
Among the all formulations, S1 shows least gel 
strength (4.0 g/s) and G3 was more (7.1 g/s). 
The formulations S2 and G2 were showed 
moderate gel strength (6.0 and 6.5 g/s 
respectively). This says increase in polymer 
concentration causes increase in gel strength 
(Table II). 
The antibacterial activity of the 
best formulations G3 was compared with the 
reference standard (pure drug). It was found 
that the zone of inhibition (in diameters) of 
formulation G3 was equal to that of                 
the reference standard. Results have showed 
that moxifloxacin is more active against 
microorganisms like Salmonella Sp. and 
Pseudomonas Sp.  as compared to Kelebsiella Sp., 
least active against E.coli. 
The in vitro diffusion profile of moxiflo-
xacin from the gels containing different 
concentration of gellan gum and sodium 
alginate based gels is shown in fig.1. The release 
of drug from these gels was characterized by an 
initial phase of high release (burst effect), the 
remaining drug was released at a slower rate 
(second phase). This biphasic pattern of release 
is a characteristic feature of matrix diffusion 
kinetics. The initial burst effect was 
considerably reduced with increase in polymer 
concentration. The formulations G1 and S1 
released maximum amount of drug (87.76 and 
82.22 % respectively) in 3 hours as compared 
to G2 and S2 (80.24 and 78.9 % respectively). 
The formulations G3 and S3 have shown 
delayed release than other formulations, among 
these two formulations G3 have shown least 
drug release in 3 hours, this says G3 was the 
best formulation than other. Finally, it was 
found that drug release was get sustaining by 
increasing the polymer concentration. 
 
Release kinetics 
The examination of the correlation 
coefficient ‘r’ indicated that the drug release 
followed diffusion controlled mechanism from 
the in situ gels (Table III), as the values of ‘r’ for 
first order (ranged from 0.910 to 0.983) found 
to be less in comparison to zero order (ranged 
from 0.912 to 0.989) and Higuchi's square root 
of time (ranged from 0.708 to 0.915). It was 
understood to be predominant zero order 
release pattern. Further, to understand the drug 
release mechanism, the data were fitted into 
Peppas exponential  model Mt/M∞=Ktn, where  
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Mt/M∞ is the fraction of drug released after 
time ‘t’ and ‘K’ is kinetic constant and ‘n’ is 
release exponent which characterizes the drug 
transport mechanism. The values ‘n’ were in 
the range of 0.290 to 1.155. The formulations 
G1, G2 and S1 were following fickian release 
mechanism (‘n’ values are less than 0.45), S2 
and S3 are indicating non-fickian release 
mechanism (‘n’ values are between 0.45-0,89) 
and G3 is following super II release (‘n’ values 
are more than 0.89).     
 
CONCLUSION 
From the above studies it can be 
concluded that local drug delivery may be an 
advantageous in treatment, since it would 
probably  eliminate  side   effects,  which  occur  
 
with systemic dosing. The local drug delivery 
system in present study is simple and easy to 
use.  Its  syringeability  allows  easy insertion  of  
gel formulation in to periodontal pocket. In situ 
gel formulation of Moxifloxacin with 
mucoadhesive properties is useful to 
prolonging local residence time at periodontal 
pocket. This type of drug delivery system can 
serve as a novel approach for treating 
periodontal diseases with better patient 
compliance. The developed formulation can 
release the drug at controlled rate for prolonged 
duration.  
An in vivo study of the formulation is 
necessary factor to evaluate the efficacy and 
safety of the novel drug delivery system. 
 




Zero order First order Higuchi Korsmeyer et al. 
R2 R2 R2 n R2 
G1 0.969 0.951 0.719 0.359 0.956 
G2 0.989 0.983 0.802 0.290 0.981 
G3 0.912 0.910 0.915 1.155 0.906 
S1 0.937 0.917 0.708 0.364 0.938 
S2 0.969 0.963 0.778 0.472 0.974 




Figure 1. Comparative drug release profile of the formulations 
(G1, G2, G3, S1, S2 and S3) 
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